Global Proliferative Diabetic Retinopathy (PDR) Market Revenue and CAGR Forecast Analysis 2025–2029

Global Proliferative Diabetic Retinopathy (PDR) Market

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Proliferative Diabetic Retinopathy (PDR) Industry By 2029?

The market size for Proliferative Diabetic Retinopathy (PDR) has seen a swift expansion in recent times. The growth is expected to rise from $2.42 billion in 2024 and reach $2.69 billion in 2025 with a compound annual growth rate (CAGR) of 11.3%. Factors like an increase in the number of diabetes cases, changes in lifestyle habits, consumption of unhealthy foods, government policies, and a surge in diabetes-induced vision loss have significantly contributed to the market growth historically.

Over the next few years, the market size for proliferative diabetic retinopathy (pdr) is anticipated to experience swift expansion. By 2029, it is projected to reach a value of $4.03 billion, with a compound annual growth rate (CAGR) of 10.6%. The projected growth within this forecast period is largely due to the increase in an aging population, heightened public awareness and education concerning diabetes, increased funding for research and development, and a rising demand for combination therapies. Significant trends within this forecast period encompass enhancements in diagnostic technologies, breakthroughs in treatment options, adoption of artificial intelligence (AI) for early diagnosis, advancements in gene therapy, and advanced retinal imaging.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12911&type=smp

Which Growth Drivers Are Shaping The Proliferative Diabetic Retinopathy (PDR) Market Outlook?

The proliferative diabetic retinopathy (PDR) market is anticipated to witness notable growth due to the expanding prevalence of diabetes. This chronic health condition is typified by heightened glucose levels in the blood. It serves as the primary cause of proliferative diabetic retinopathy disease, a condition which can be managed by different methods to prevent further harm to the retina and maintain quality of vision. For example, data in June 2024 from the National Health Service (NHS), a department of the UK government, showed an increase in diabetes cases among those below 40, escalating from 173,166 in 2022 to 216,440 in 2023. This represents a worrying development within this demographic group. The figures display a swift surge in diabetes prevalence amongst younger demographics. This heightening prevalence of diabetes thus fuels the growth of the proliferative diabetic retinopathy (PDR) market.

How Is The Global Proliferative Diabetic Retinopathy (PDR) Market Broken Down By Segment?

The proliferative diabetic retinopathy (pdr)market covered in this report is segmented –

1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy; Intraocular Steroids; Laser Surgery; Vitrectomy

2) By Mode of Administration: Injectables; Oral; Other Mode Of Administrations

3) By Application: Hospitals; Clinics; Other Applications

Subsegments:

1) By Anti-VEGF Therapy: Aflibercept; Ranibizumab; Bevacizumab

2) By Intraocular Steroids: Triamcinolone Acetonide; Dexamethasone Implant; Fluocinolone Acetonide

3) By Laser Surgery: Focal Laser Photocoagulation; Panretinal Laser Photocoagulation

4) By Vitrectomy: Pars Plana Vitrectomy; Anterior Vitrectomy

Which Notable Trends Are Transforming The Proliferative Diabetic Retinopathy (PDR) Market Outlook?

Leading corporations in the proliferative diabetic retinopathy industry are consistently investing in the creation of innovative therapeutic approaches, with the goal of boosting the efficacy of treatments, decreasing the demands they place on patients, and enhancing patient outcomes. An illustration of this occurred in June 2022, when the American biotech firm Biogen, in coordination with Samsung Bioepis, a South Korean biotechnology company, unveiled Byooviz (ranibizumab-nuna). Notably, this was the inaugural ophthalmology biosimilar in the United States, and it’s used to tackle health conditions such as diabetic macular edema, proliferative diabetic retinopathy, neovascular age-related macular degeneration (wet AMD), and choroidal neovascularization.

Who Are The Primary Market Leaders In The Proliferative Diabetic Retinopathy (PDR) Market?

Major companies operating in the proliferative diabetic retinopathy (pdr) market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Merck KGaA, Kubota Vision Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Santen Pharmaceutical Co. Ltd., Lupin Limited, Genentech Inc., Sirnaomics Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/proliferative-diabetic-retinopathy-pdr-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Proliferative Diabetic Retinopathy (PDR) Market?

North America was the largest region in the proliferative diabetic retinopathy market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in proliferative diabetic retinopathy (PDR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12911&type=smp

Browse Through More Reports Similar to the Global Proliferative Diabetic Retinopathy (PDR) Market 2025, By The Business Research Company

Digital Diabetes Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

Diabetes Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

Pet Diabetes Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model